Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2026 · 10-Q
Revenue$7.78M$7.78M−1.9% vs Q2 2025 Net Income$554.59K$554.59K+55.9% vs Q2 2025 EPS Diluted$0.07$0.07+75.0% vs Q2 2025 Operating Income$1,197,341−19.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,813,210+181.3% Margins · derivedOperating margin15.4%−3.4 pt vs Q2 2025
Net margin7.1%+2.6 pt vs Q2 2025
ended May 31, 2026 · filed Jul 15, 2026 · 45 d after period end